KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) FCF Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed FCF Margin for 6 consecutive years, with 1979000.0% as the latest value for Q3 2023.

  • On a quarterly basis, FCF Margin rose 197886418.0% to 1979000.0% in Q3 2023 year-over-year; TTM through Sep 2023 was 80.4%, a 1621.0% decrease, with the full-year FY2024 number at 238517.24%, down 262640276.0% from a year prior.
  • FCF Margin was 1979000.0% for Q3 2023 at Twist Bioscience, up from 6.62% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1979000.0% in Q3 2023 to a low of 318.23% in Q1 2020.
  • A 5-year average of 104040.69% and a median of 121.48% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -13689bps in 2020, then skyrocketed 197886418bps in 2023.
  • Twist Bioscience's FCF Margin stood at 215.4% in 2019, then surged by 53bps to 101.42% in 2020, then plummeted by -39bps to 141.45% in 2021, then grew by 14bps to 121.48% in 2022, then soared by 1629185bps to 1979000.0% in 2023.
  • Per Business Quant, the three most recent readings for TWST's FCF Margin are 1979000.0% (Q3 2023), 6.62% (Q2 2023), and 88.64% (Q1 2023).